| Edward Allen Sullivan Iii, MD | |
|
619 19th St S, Birmingham, AL 35249 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | Edward Allen Sullivan Iii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 31 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275596926 | NPI | - | NPPES |
| 51550443 | Other | AL | BLUE CROSS/BLUE SHIELD |
| 51518308 | Other | AL | BLUE CROSS/BLUE SHIELD |
| 051550443 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 21618 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Brookwood Baptist Medical Center | Birmingham, AL | Hospital |
| Riverview Regional Medical Center | Gadsden, AL | Hospital |
| Russell Medical Center | Alexander city, AL | Hospital |
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of Birmingham, P.c. | 7214928571 | 37 |
| Urology Centers Of Alabama Pc | 0941264345 | 57 |
| Radiology Associates Of Birmingham, P.c. | 7214928571 | 37 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | Norwood Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104879741 PECOS PAC ID: 8921996364 Enrollment ID: O20040308001107 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | Radiology Associates Of Birmingham, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093778706 PECOS PAC ID: 7214928571 Enrollment ID: O20040524001193 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | St Vincent's Pet Center Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1457337073 PECOS PAC ID: 4981673001 Enrollment ID: O20040927000414 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | Urology Centers Of Alabama Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710962550 PECOS PAC ID: 0941264345 Enrollment ID: O20041116000389 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | St Vincents Ambulatory Healthcare Network Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1588190441 PECOS PAC ID: 1355608456 Enrollment ID: O20171128001387 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | St Vincents Ambulatory Healthcare Network Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1033646823 PECOS PAC ID: 1355608456 Enrollment ID: O20180626000597 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Entity Name | Cooper Green Mercy Health Services Authority An Affiliate Of Uab |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366073108 PECOS PAC ID: 0840629473 Enrollment ID: O20200402003238 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Allen Sullivan Iii, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Edward Allen Sullivan Iii, MD 619 19th St S, Birmingham, AL 35249 Ph: (205) 934-4011 |
News Archive
Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
Today US District Judge Edward R. Korman ordered the FDA to make the morning after pill available to 17-year-old minor girls without a physician's visit or prescription and without parental consent.
Current research suggests that the inflammatory molecule TNF-α may contribute to delayed bone fracture healing in diabetics. The related report by Alblowi et al, "High Levels of TNF-α Contribute to Accelerated Loss of Cartilage in Diabetic Fracture Healing" appears in the October 2009 issue of the American Journal of Pathology.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
› Verified 7 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |